General Dermatology

New research shows the 675-nm laser enhances skin texture and rejuvenation, making it a valuable tool for various dermatological conditions.

Citius' recently-approved Lymphir has been added to the National Comprehensive Cancer Network's Clinical Practice Guidelines in Oncology.

The phase 2 trial for EVO756, targeting mast cell-related CIndU, is now underway at 15 US study sites.

Dermatology Times is looking back on the top stories in dermatology from the month of August.

Dermatology Times is recapping our top expert interviews from the month of August.

Researchers observed significant improvements in roughness and redness in patients treated with the non-cross-linked compound.

A recent review highlighted how AI can be used to enhance diagnostic accuracy, consultations, treatment planning, and patient education.

The findings support the idea that Botox can enhance emotional well-being and self-confidence, although it did not notably impact the quality of life.

Bullous pemphigoid in youth is rare and can be missed due to negative BP180 ELISA results, complicating timely diagnosis in children.

A recent study confirmed that collagen peptides effectively counteract age-related skin issues such as reduced density and increased dryness.

Researchers identified mistrust, social stigma, and language barriers as major obstacles for ethnic minorities in skin research.

After treatment with the topical JAK inhibitor, researchers reported significant improvement of lesional skin.

In a review, researchers reported that ethnicity plays a role in outcomes, presentations, and more for individuals with systemic sclerosis.

This week’s collection of the latest dermatologic studies includes the prevalence of vulvar dermatoses among ethnically diverse patients, the adaptation of the Mackie melanoma risk stratification tool into a tablet-based patient questionnaire, siblings diagnosed with hereditary sensory and autonomic neuropathy, and more.

Researchers say promising study findings warrant further exploration of EID's potential on a larger scale.

A review found repeated laser treatments show cumulative benefits, including improved collagen density and skin elasticity over time.

Patients with AD and psoriasis both report diminished levels of happiness compared to the general population.

Researchers assessed patterns of referral from a primary dermatological clinic in Japan.

Preliminary data suggests that the exosomes could effectively address common skin concerns, including firmness, photodamage, and fine lines.

Health care professionals are recognizing the growing need for advanced technology in modern medical practice.

Explore recent research in in vitro complex skin models to study skin homeostasis, aging, and skin disease.

“This approval reflects our dedication to ensuring high-quality treatments are universally accessible,” Claire D’Abreu-Hayling, chief scientific officer of Sandoz, said in a news release.

Since the first electronic medical record emerged in 1972, clinicians have found themselves increasingly trapped behind screens.

Despite high accuracy scores, the study found AI models often produce overly complex explanations, making them less effective for patient education.

Myron Czuczman, MD, of Citius Pharmaceuticals recently shared perspectives on the role and potential of Lymphir in CTCL.